3.0
15. Okt. 2010
Aktueller Mitarbeiter
Cambridge, MA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Exposure, resources, big pharma work culture, get to meet doctors and patients aswell, stable job, slow but steady promotions, great work llife balance
Kontras
slow growth, monetary compensation not the best, not a good retainer of employees, too diversified, great gap between research and translational science, data access at research not great